Today an announcement was made by an Australian company about the further progress in its clinical trials of dendrimer Dep Docetaxel
Currently Sanofi - Aventis has a drug called Taxotere which is marketed throughout the world to help cancer patients. It's patent ran out in 2010, however at that time it was creating revenue of more than 3 billion dollars for the company
This new drug (dendrimer Dep Docetaxel) which is being taken through clinical trials in Australia has a superior efficacy and no currently exhibited side effects which Taxotere have shown
